Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 81 - 90 of 416

Selected Filters:
2 September 2024

Meta-analysis of Pregnancy Events in Biomedical HIV Prevention Trials in Sub-Saharan Africa: Implications for gender transformative trials

This article from AIDS and Behavior describes the results of a meta-analysis of pregnancy events in biomedical HIV prevention trials in sub-Saharan Africa undertaken to support trialists moving toward more inclusive clinical and implementation studies for pregnant and lactating people.

Research

External Link
2 September 2024

PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice

This review from Current HIV/AIDS Reports draws parallels between HIV prevention and family planning by summarizing how method choice and product switching affected contraceptive coverage globally, synthesizes what is known about PrEP product switching, and outlines evidence gaps to help guide future research on PrEP switching in the context of choice.

Research

External Link
20 August 2024

The Long Wait for Long-acting HIV Prevention and Treatment Formulations

This commentary from The Lancet HIV calls on WHO, financial donors, manufacturers, and governments to take coordinated action to make long-acting HIV prevention and treatment available at scale in lower and middle income countries.

Community/Advocacy, Research, Service Delivery

Document
16 August 2024

Harnessing Private Sector Strategies for Family Planning to Deliver the Dual Prevention Pill, the First Multipurpose Prevention Technology with Pre-exposure Prophylaxis, in an Expanding HIV Prevention Landscape

This article from the Journal of the International AIDS Society describes the results of a scoping exercise to evaluate different private sector delivery channels for the Dual Prevention Pill in Kenya, South Africa, and Zimbabwe.

Research, Service Delivery

External Link
15 August 2024

Let’s Talk LEN: What global advances in HIV prevention mean for Black communities in the US

Groundbreaking results from the PURPOSE 1 trial conducted among cisgender Ugandan and South African women have changed the injectable PrEP global landscape. This webinar will explore the implications of these findings for US Black populations. Moderators: John Meade Jr., Senior Program Manager, Policy at AVAC & Founding Member of PrEP in Black America (PIBA) Leisha…

Community/Advocacy, Research

Event
12 August 2024

PrEP Your Booty: The Launch of HPTN 106 “Rev Up”

Recording / Slides / Resources HPTN 106 (REV UP) is an innovative clinical trial from the HIV Prevention Trials Network that will investigate the safety and acceptability of a tenofovir-based rectal douche for HIV prevention among cisgender men and transgender women who have sex with men. Hear directly from researchers leading the study during this…

Research

Event
8 August 2024

Online pharmacy PrEP and PEP: Evidence, learnings, and recommendations from Kenya

Click here to access the recording. Private and community pharmacies, coupled with online pharmacy/telehealth platforms, hold promise as convenient pathways to enhance access and effective use of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). To generate evidence on the feasibility and effectiveness of an online pharmacy to support PrEP and PEP initiation, continuation, and PEP-to-PrEP…

Research, Service Delivery

Event
5 August 2024

PURPOSE 1 Summary

This factsheet provides a summary of the PURPOSE 1 phase III clinical trial of lenacapavir for PrEP and F/TAF for cisgender women taking place in South Africa and Uganda.

Research

Document
5 August 2024

Client Experiences with “Dynamic Choice Prevention,” a Model for Flexible Patient-centred HIV Prevention Delivery in Rural Eastern Africa

This article from Journal of the International AIDS Society discusses client experiences of a dynamic choice model for HIV prevention piloted in Kenya and Uganda under the SEARCH study, where clients were supported to select HIV prevention method, testing mode, and service delivery channel from a range of options.

Research, Service Delivery

External Link
30 July 2024

HIV Pre-Exposure Prophylaxis Policies Worldwide

An analysis presented at IAS2024, HIV Pre-Exposure Prophylaxis Policies Worldwide, by the Georgetown University Center for Global Health Policy & Politics, has found 69% of 194 countries reviewed have approved at least one PrEP product. But only 52% of the countries reviewed follow WHO guidance on PrEP eligibility with regulatory approvals and national policies that…

Normative Guidance/Policies, Research

Document